Pharmacom Labs | TESOS (Tesofensine) | 2024-01 | Janoshik

RThoads

Subscriber
TESOS: Tesofensine from Pharmacom Labs

Analytic testing performed by Janoshik.

RESULTS:
m4RE0iE.jpeg

1. Qualitative analysis: the sample contains the active ingredient Tesofensine.
2. Quantitative analysis showed the content of active ingredient: 0.395 mg.

Analysis conducted: 05 January 2024
 
It serves as a Triple reuptake inhibitor with mild DRI properties, which would mitigate it's addiction potential. I would use it for an anti-depressant and as most a med that works centrally to mitigate appetite and or binging. It has some potential for ADHD so I may be able to be less reliant on addreral XR and methylphenidate.
It increases cholinergic transmission and enhanced BDNF expression. I would assume its devoid of excessive weight gain, fatigue and Sexual side effects, unlike ssri's and to a lesser degree snri's.
I have zero experience with it as it costs an arm and a leg and can be tricky to source.
Have you tried it or are you contemplating ?
 
Back
Top